{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:48:20Z","timestamp":1793155700957,"version":"4.5.0"},"reference-count":32,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022768","name":"Maire Lisko Foundation","doi-asserted-by":"publisher","award":["No ID or numbers used. Funded in 2023"],"award-info":[{"award-number":["No ID or numbers used. Funded in 2023"]}],"id":[{"id":"10.13039\/501100022768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"Helsingin Yliopisto","doi-asserted-by":"publisher","award":["Open access funded by the University Library"],"award-info":[{"award-number":["Open access funded by the University Library"]}],"id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,1,6]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to explore the association between lipid-based Cardiovascular Event Risk Tests (CERT1 and CERT2), including ceramides (Cer) and phosphatidylcholine (PC) lipid species, and rheumatoid arthritis (RA), an inflammatory disease that can increase the risk of cardiovascular diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective population-based cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Primary care centres across five geographical areas in Finland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study included 7702 individuals (selected from the FINRISK cohort) who were assessed for the prevalence and incidence of RA. At baseline, the cohort included 7518 RA-free individuals, among whom 329 developed RA during the study, and 184 had a history of RA at baseline. Serum levels of ceramides and PC were measured using mass spectrometry, and CERT scores were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Prevalence and incidence of RA, CERT scores, and serum lipid levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CERT scores were associated with prevalent RA but not with incident RA in the full cohort. Adjusted ORs and 95% CI for prevalent RA were 1.24 (95% CI 1.05 to 1.46) for CERT1 and 1.42 (95% CI 1.20 to 1.68) for CERT2. Stratified analyses showed that these associations were consistent among individuals over 50 years of age and across both sexes. The Cer (d18:1\/16:0)\/PC (16:0\/22:5) ratio was significantly associated with RA in younger individuals (OR 1.66; 95%\u2009CI (1.26 to 2.18)). Overall, the association between lipids and RA was stronger in women than men.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study shows a significant association between prevalent RA and bioactive lipid species used for cardiovascular risk assessment. These findings emphasise the importance of considering residual inflammatory risks, such as RA, in cardiovascular risk evaluations in clinical settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-090486","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:51:41Z","timestamp":1741755101000},"page":"e090486","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Association of ceramide risk scores with rheumatoid arthritis: a FINRISK population-based cohort study"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4858-3167","authenticated-orcid":false,"given":"Mohammadreza","family":"Shoghli","sequence":"first","affiliation":[{"name":"Population Health, University of Helsinki Faculty of Medicine, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Sinisalo","sequence":"additional","affiliation":[{"name":"Heart and Lung Center, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Inkeri","family":"Lokki","sequence":"additional","affiliation":[{"name":"Heart and Lung Center, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland"},{"name":"Department of Bacteriology and Immunology, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0636-6567","authenticated-orcid":false,"given":"Mitja","family":"L\u00e4\u00e4peri","sequence":"additional","affiliation":[{"name":"Zora Biosciences Oy, Espoo, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja-Liisa","family":"Lokki","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0663-5843","authenticated-orcid":false,"given":"Mika","family":"Hilvo","sequence":"additional","affiliation":[{"name":"VTT Technical Research Centre of Finland Ltd, Espoo, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Jylh\u00e4","sequence":"additional","affiliation":[{"name":"Zora Biosciences Oy, Espoo, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaakko","family":"Tuomilehto","sequence":"additional","affiliation":[{"name":"Population Health Unit, Finnish Institute for Health and Welfare, University of Helsinki, Helsinki, Finland"},{"name":"Department of Public Health, University of Helsinki, Helsinki, Finland"},{"name":"Department of International Health, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reijo","family":"Laaksonen","sequence":"additional","affiliation":[{"name":"Zora Biosciences Oy, Espoo, Finland"},{"name":"Finnish Cardiovascular Research Centre, University of Tampere, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"2025121409583118000_15.3.e090486.1","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00125-018-4590-6","article-title":"Ceramide stearic to palmitic acid ratio predicts incident diabetes","volume":"61","author":"Hilvo","year":"2018","journal-title":"Diabetologia"},{"key":"2025121409583118000_15.3.e090486.2","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeab010","article-title":"Absolute and relative risk prediction in cardiovascular primary prevention with a modified SCORE chart incorporating ceramide-phospholipid risk score and diabetes mellitus","volume":"1","author":"Hilvo","year":"2021","journal-title":"Eur Heart J Open"},{"key":"2025121409583118000_15.3.e090486.3","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11090632","article-title":"A Randomized Controlled Dietary Intervention Improved the Serum Lipid Signature towards a Less Atherogenic Profile in Patients with Rheumatoid Arthritis","volume":"11","author":"Lindqvist","year":"2021","journal-title":"Metabolites"},{"key":"2025121409583118000_15.3.e090486.4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.050377"},{"key":"2025121409583118000_15.3.e090486.5","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1021\/acs.jproteome.3c00574","article-title":"Precise Lipidomics Decipher Circulating Ceramide and Sphingomyelin Cycle Associated with the Progression of Rheumatoid Arthritis","volume":"22","author":"Luan","year":"2023","journal-title":"J Proteome Res"},{"key":"2025121409583118000_15.3.e090486.6","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13063"},{"key":"2025121409583118000_15.3.e090486.7","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15044"},{"key":"2025121409583118000_15.3.e090486.8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16040789","article-title":"Therapeutic Potential for Sphingolipids in Inflammatory Bowel Disease and Colorectal Cancer","volume":"16","author":"Espinoza","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2025121409583118000_15.3.e090486.9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.969408","article-title":"Metabonomic analysis of abnormal sphingolipid metabolism in rheumatoid arthritis synovial fibroblasts in hypoxia microenvironment and intervention of geniposide","volume":"13","author":"Ke","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025121409583118000_15.3.e090486.10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052719","article-title":"Ceramides as Mediators of Oxidative Stress and Inflammation in Cardiometabolic Disease","volume":"23","author":"Gaggini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025121409583118000_15.3.e090486.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00281.x"},{"key":"2025121409583118000_15.3.e090486.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2015.09.002"},{"key":"2025121409583118000_15.3.e090486.13","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/248135","article-title":"Sphingolipid and ceramide homeostasis: potential therapeutic targets","volume":"2012","author":"Young","year":"2012","journal-title":"Biochem Res Int"},{"key":"2025121409583118000_15.3.e090486.14","doi-asserted-by":"crossref","DOI":"10.1186\/ar4604","article-title":"The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation","volume":"16","author":"Hao","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025121409583118000_15.3.e090486.15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/365557a0","article-title":"Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens","volume":"365","author":"Olivera","year":"1993","journal-title":"Nature New Biol"},{"key":"2025121409583118000_15.3.e090486.16","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200157","article-title":"Sphingosine-1-phosphate in anti-neutrophil cytoplasmic antibody-associated vasculitis: coagulation-related clinical indicators and complications","volume":"40","author":"Wu","year":"2020","journal-title":"Biosci Rep"},{"key":"2025121409583118000_15.3.e090486.17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI76369"},{"key":"2025121409583118000_15.3.e090486.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.06.028"},{"key":"2025121409583118000_15.3.e090486.19","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12247524","article-title":"The Novel Ceramide- and Phosphatidylcholine-Based Risk Score for the Prediction of New-Onset of Hypertension","volume":"12","author":"Shoghli","year":"2023","journal-title":"J Clin Med"},{"key":"2025121409583118000_15.3.e090486.20","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/cku174"},{"key":"2025121409583118000_15.3.e090486.21","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx239"},{"key":"2025121409583118000_15.3.e090486.22","doi-asserted-by":"crossref","first-page":"570628","DOI":"10.3389\/fendo.2020.570628","article-title":"Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification","volume":"11","author":"Hilvo","year":"2020","journal-title":"Front Endocrinol"},{"key":"2025121409583118000_15.3.e090486.23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1172\/jci.insight.121326","article-title":"Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention","volume":"3","author":"Mundra","year":"2018","journal-title":"JCI Insight"},{"key":"2025121409583118000_15.3.e090486.24","unstructured":"R Core Team . Vienna, Austria; R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2023. Available: https:\/\/www.R-project.org"},{"key":"2025121409583118000_15.3.e090486.25","unstructured":"Therneau T . A Package for Survival Analysis in R. R package version 3.5-7, 2023. Available: https:\/\/CRAN.R-project.org\/package=survival"},{"key":"2025121409583118000_15.3.e090486.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2016.10.006"},{"key":"2025121409583118000_15.3.e090486.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0428-y"},{"key":"2025121409583118000_15.3.e090486.28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015258","article-title":"Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy","volume":"9","author":"Hilvo","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025121409583118000_15.3.e090486.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091769","article-title":"Sphingolipids in human synovial fluid--a lipidomic study","volume":"9","author":"Kosinska","year":"2014","journal-title":"PLoS One"},{"key":"2025121409583118000_15.3.e090486.30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/OARRR.S306378","article-title":"Influence of Age and Sex on Disease Course and Treatment in Rheumatoid Arthritis","volume":"13","author":"Nilsson","year":"2021","journal-title":"Open Access Rheumatol"},{"key":"2025121409583118000_15.3.e090486.31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12016-018-8672-5","article-title":"Sex and Management of Rheumatoid Arthritis","volume":"56","author":"Favalli","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025121409583118000_15.3.e090486.32","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00267-8"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-090486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:58:39Z","timestamp":1765735119000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-090486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,12]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bmjopen-2024-090486"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-090486","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}